Fingerprint
Dive into the research topics where Huifang Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Infections Due to Corynebacterium kroppenstedtii With Focus on Granulomatous Lobular Mastitis for Tissue Specificity, Pathogenesis, Bacteriologic Workup, and Treatment
Gan, Q., Ding, Y., Wu, Y., Zhang, Y., Meng, Q. H., Ding, Q. Q., Lu, H., Shelburne, S. A., Ehlers, R. A. & Han, X. Y., Sep 1 2025, In: Archives of pathology & laboratory medicine. 149, 9, p. 812-821 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Inflammatory Arthritis Post Immune Checkpoint Inhibitor Therapy
Bowman, S., Amaria, R. N. & Lu, H., Jan 1 2025, Challenging Cases in Immunotherapy Related Organ Toxicities. Springer Science+Business Media, p. 417-423 7 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Managing Rheumatoid Arthritis in Older Adults with Cancer
Lopez-Olivo, M. A., Matusevich, A. R. K., Tayar, J. H. & Lu, H., Jul 2025, In: Drugs and Aging. 42, 7, p. 599-614 16 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
More Than Medicine: The Hope, Hurdles, and Hidden Costs of IgG Therapy
Boldt, C. & Lu, H., Jul 1 2025, In: Journal of Immunotherapy and Precision Oncology. 8, 3, p. 191-193 3 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Polymyalgia Rheumatica-Like Syndrome Post Immune Checkpoint Inhibitor Therapy
Lu, H., Linda Bobby, N. P., Tayar, J., Bowman, S., Kim, S. T. & Msaouel, P., Jan 1 2025, Challenging Cases in Immunotherapy Related Organ Toxicities. Springer Science+Business Media, p. 433-438 6 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter